| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 222.56 | 4.0% | 12.9% |
| Total Income | 222.56 | 4.0% | 12.9% |
| Expenditure | 179.53 | 4.3% | 12.0% |
| PBT | 21.56 | 13.2% | 5.8% |
| Net Profit | 11.05 | 11.6% | 15.9% |
| OPM | 11.28% | 1.03pp | 1.57pp |
| NPM | 4.96% | 0.34pp | 1.70pp |
| EPS | -1.04 | 516.0% | 316.7% |
USPH Reports Q3 2026 Results, Record High Visits and Revenue Per Visit
07 Nov 2026 · 7 Nov, 2:48 am
Summary
U.S. Physical Therapy, Inc. reported a 13% increase in total net revenue to $223 million for the third quarter of 2026, driven by strong performance in both physical therapy and industrial injury prevention services. While net income attributable to shareholders decreased slightly to $11 million from $13 million year-over-year, adjusted EBITDA saw a positive trend, rising to $28 million from $24 million. Management highlighted the initial benefits of hospital affiliations and ongoing expense control efforts, expressing optimism for continued growth into 2027.
Key Highlights
- 1
Total net revenue increased by 13% to $223 million for the third quarter ended September 30, 2026, compared to the prior year period.
- 2
Net income attributable to USPH shareholders was $11 million for Q3 2026, compared to $13 million for Q3 2025.
- 3
Adjusted EBITDA for Q3 2026 was $28 million, an increase from $24 million in Q3 2025.
- 4
Physical therapy net revenue per patient visit was $111 for Q3 2026, a $5 increase compared to Q3 2025.
- 5
The Company's Board of Directors declared a quarterly dividend of $0.46, payable on December 11, 2026.
- 6
Through the end of Q3 2026, the Company successfully integrated all 72 clinics under the two previously announced hospital affiliation agreements.
Management Comments
Chris Reading
We are pleased with the strong financial performance delivered in the third quarter 2026. The year-over-year EBITDA improvement reflects the initial benefit of the completed rollout of our first two hospital affiliations. The 72 clinics operating under hospital affiliation agreements generated $25 million in revenue in Q3, and we expect this number to increase significantly as referral volumes rise, additional clinics are incorporated into existing agreements, and our pipeline of hospital prospects results in new affiliations. Cost pressures from our self-insured employee medical program continued in Q3. As a result, we implemented expense control efforts that partially mitigated these overages during the quarter and will benefit future periods. I want to thank our partners, clinicians, and support staff for their efforts on all fronts as we work to close out 2026, accelerate into 2027, and provide the outstanding patient service for which we are known.
Informational and educational content only. Not investment advice.